Evidence map›Paper›PMID 20548951›Full record

ArticlePLoS genetics2010

The E1A-associated p400 protein modulates cell fate decisions by the regulation of ROS homeostasis.

Lise Mattera, Céline Courilleau, Gaëlle Legube, Takeshi Ueda, Rikiro Fukunaga, Martine Chevillard-Briet, Yvan Canitrot, Fabrice Escaffit, Didier Trouche

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Chromatin Modifier EP400 Regulates Oocyte Quality and Zygotic Genome Activation in Mice.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. DNA repair: Chromatin remodeling without H2A.Z?Cell cycle (Georgetown, Tex.) · 2014
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence.Clinical cancer research : an official journal of the American Association for Cancer Research · 2012
    Article
  18. Article
  19. Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Lise MatteraLaboratoire de Biologie Cellulaire et Moléculaire du Contrôle de la Prolifération, CNRS and Université de Toulouse, Toulouse, France.
Céline Courilleau
Gaëlle Legube
Takeshi Ueda
Rikiro Fukunaga
Martine Chevillard-Briet
Yvan Canitrot
Fabrice Escaffit
Didier Trouche
Université Fédérale de Toulouse Midi-Pyrénées · FRUniversité Toulouse III - Paul Sabatier · FRCentre National de la Recherche Scientifique · FRKyoto University · JPPrincess Margaret Cancer Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The p400 E1A-associated protein, which mediates H2A.Z incorporation at specific promoters, plays a major role in cell fate decisions: it promotes cell cycle progression and inhibits induction of apoptosis or senescence. Here, we show that p400 expression is required for the correct control of ROS metabolism. Depletion of p400 indeed increases intracellular ROS levels and causes the appearance of DNA damage, indicating that p400 maintains oxidative stress below a threshold at which DNA damages occur. Suppression of the DNA damage response using a siRNA against ATM inhibits the effects of p400 on cell cycle progression, apoptosis, or senescence, demonstrating the importance of ATM-dependent DDR pathways in cell fates control by p400. Finally, we show that these effects of p400 are dependent on direct transcriptional regulation of specific promoters and may also involve a positive feedback loop between oxidative stress and DNA breaks since we found that persistent DNA breaks are sufficient to increase ROS levels. Altogether, our results uncover an unexpected link between p400 and ROS metabolism and allow deciphering the molecular mechanisms largely responsible for cell proliferation control by p400.

Indexed as

HomeostasisCell Line, TumorCell ProliferationDNA-Binding ProteinsDNA DamageDNA HelicasesGene Expression RegulationHumansOligonucleotide Array Sequence AnalysisOxidative StressReactive Oxygen SpeciesRNA, Small InterferingSignal TransductionTranscription, GeneticDNA-Binding ProteinsDNA HelicasesEP400 protein, humanReactive Oxygen SpeciesRNA, Small Interfering

Identifiers

PMID20548951
PMCPMC2883595
OpenAlexW2017964332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.